What is Ceryx Medical?
Ceryx Medical is a specialized medical technology firm focused on the development of advanced bioelectronics. The company utilizes unique, patent-protected chip technology designed to mimic Central Pattern Generators (CPGs)—the neural circuits responsible for controlling rhythmic autonomic processes such as heart rate, peristalsis, and locomotion. By creating artificial CPGs, Ceryx Medical aims to restore physiological function in patients suffering from chronic disease or traumatic injury. This deeptech innovation represents a significant shift in how medical professionals might address autonomic dysfunction, moving beyond traditional pharmaceutical interventions toward precise, hardware-based neural regulation.
How much funding has Ceryx Medical raised?
Ceryx Medical has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$4.8M
Other Financing Round
$6.8M
Angel/Seed (2022): $4.8M with participation from BGF, Icehouse Ventures, Development Bank of Wales, and Parkwalk Advisors
Other Financing Round (2025): $6.8M led by BGF, Development Bank of Wales, and Parkwalk Advisors
Key Investors in Ceryx Medical
BGF
BGF is a prominent UK-based investment firm specializing in providing growth capital to small and mid-sized businesses across diverse economic sectors.
Development Bank of Wales
The Development Bank of Wales provides sustainable financial solutions and equity support to technology ventures, backed by the Welsh Government to foster regional innovation.
Parkwalk Advisors
Parkwalk Advisors is a leading investor in university spinouts, focusing on bridging the gap between academic deeptech research and commercial market success.
What's next for Ceryx Medical?
With the recent influx of capital, Ceryx Medical is well-positioned to scale its operational capabilities and advance its core technology through rigorous clinical validation. The strategic focus will likely center on refining its artificial CPG hardware to meet regulatory standards while expanding its intellectual property portfolio. As the company matures, the emphasis will shift toward establishing clinical partnerships and preparing for potential market entry. The continued support from its investor base suggests a long-term commitment to scaling this transformative health technology, ensuring that Ceryx Medical remains a key player in the evolving landscape of bioelectronic therapeutics.
See full Ceryx Medical company page
